Karen Pekle
- Hematology top 2%
- Molecular Biology
- Oncology top 10%
- Immunology
- Epidemiology
- Co-authors
- Roger PearseRubén NiesvizkyMorton ColemanAndrew L. PecoraNA KernanCA KeeverP BlackNeal Flomenberg
- Topics
- Multiple Myeloma Research and Treatments (31 papers)Protein Degradation and Inhibitors (17 papers)Cancer Treatment and Pharmacology (11 papers)
- Cited by
- HematologyImmunologyOncology
- Partner nations
- United StatesGermany
In The Last Decade
Karen Pekle
39 papers receiving 647 citations
Peers
Comparison fields: 5 of 48
- Hematology 484
- Molecular Biology 254
- Oncology 238
- Immunology 208
- Epidemiology 122
Countries citing papers authored by Karen Pekle
This map shows the geographic impact of Karen Pekle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Pekle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Pekle more than expected).
Fields of papers citing papers by Karen Pekle
This network shows the impact of papers produced by Karen Pekle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Pekle. The network helps show where Karen Pekle may publish in the future.
Co-authorship network of co-authors of Karen Pekle
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Pekle. A scholar is included among the top collaborators of Karen Pekle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Pekle. Karen Pekle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 4 | |
| 4 | 6 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 20 | |
| 10 | 2 | |
| 11 | 39 | |
| 12 | 13 | |
| 13 | 55 | |
| 14 | 60 | |
| 15 | 8 | |
| 16 | 11 | |
| 17 | 19 | |
| 18 | 5 | |
| 19 | 14 | |
| 20 | 210 |
About Karen Pekle
Karen Pekle is a scholar working on Hematology, Oncology and Molecular Biology, having authored 39 papers that have together received 656 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (31 papers), Protein Degradation and Inhibitors (17 papers) and Cancer Treatment and Pharmacology (11 papers). The work is most often cited by research in Hematology (484 citations), Immunology (208 citations) and Oncology (238 citations). Karen Pekle has collaborated with scholars based in United States and Germany. Frequent co-authors include Roger Pearse, Rubén Niesvizky, Morton Coleman, Andrew L. Pecora, NA Kernan, CA Keever, P Black, Neal Flomenberg, TN Small and Glenn Heller. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.